Article
Coexpression of LAG-3 and PD-L1 in tumor infiltrating immune cells predicts worse outcome in clear cell renal cell carcinoma
2022-03-07
Abstract excerpt
Lymphocyte-activation gene 3 (LAG-3) protein is a potential immune checkpoint target for cancer treatment. Thus, we investigated LAG-3 expression and its prognostic value in clear cell renal cell carcinoma (ccRCC) and correlated LAG-3 expression with programmed cell death ligand 1 (PD-L1) using immunohistochemistry on tissue microarrays incorporating 134 ccRCC primary excision specimens. The study patients were an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 009b37b3-e074-5559-8361-9d562aefadee
- DOI
- 10.21203/rs.3.rs-1413598/v1
